Conference abstractPublished 24 Mar 2014
Differential role of Fus3p MAPK and its phosphorylation target Far1p in the cell death induced by an and#945;-pheromone-like peptide in Saccharomyces cerevisiae
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The Iztli peptide 1 (IP-1) is a hunter-killer peptide with 19 residues: 13 residues correspond to the α-pheromone sequence from Saccharomyces cerevisiae and the other 6 residues provide the 19mer peptide with antimicrobial activity. In this design, one single functional domain (antimicrobial activity) combines two activities. This renders a peptide with an emerging property: to kill MAT a cells from S. cerevisiae . While high concentrations of α-pheromone have proven to induce the cell death of MAT a cells, IP-1 at lower concentration kills many more cells than the pheromone; moreover the cell death induced by Iztli seems to be independent from apoptosis-like death as opposed to the α-pheromone(1). Screening for every gene deletion involved in the α-pheromone signaling pathway, we found that the genes coding for the MAPK cascade proteins protect from the cell death induced by IP-1 with different degrees. STE11 (MAPKKK) and STE7 (MAPKK) absence have full protective effect against IP-1 action, while FUS3 (MAPK) absence protects only partially. Fus3p when active, phosphorylates/activates Far1p, the latter protein is responsible for cell cycle arrest. Despite ∆FUS3 has a partial protection against IP-1 induced death, cells lacking FAR1 recover a phenotype similar to D STE11 and D STE7 . By contrast, all these genes have a degree of protection against the cell cycle arrest induced by the α-pheromone that significantly differ from the cell death protection against IP-1. These results indicate that IP-1 may be able to differently activate the MAPK pathway. We are currently testing this new mechanism of activation with double deletion mutants and with Western Blot assays.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMetabolomics:Open Access
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Paula Martinell García”
